Status | Study |
Recruiting |
Study Name: Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases Condition: Other Specified Inflammatory Disorders of Skin or Subcutaneous Tissue Date: 2013-09-17 Interventions: Procedure: Collection of biological samples |
Completed |
Study Name: Proof of Concept Study of Gevokizumab in the Treatment of Pyoderma Gangrenosum Condition: Pyoderma Gangrenosum Date: 2013-06-17 Interventions: Drug: gevokizumab |
Completed |
Study Name: Canakinumab for Pyoderma Gangrenosum Condition: Pyoderma Gangrenosum Date: 2011-02-17 Interventions: Drug: Canakinumab Monoclonal antibody inhibiting interleukin 1 beta |
Completed |
Study Name: Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's Disease Condition: Crohn Disease Date: 2010-11-02 Interventions: Drug: Tacrolimus Once daily application for 12 weeks followed by 4 weeks observation. Optional 36 week o |
Completed |
Study Name: Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease Condition: Pyoderma Gangrenosum Crohn's Disease Date: 2008-11-13 Interventions: Drug: Infliximab IV drug given at weeks 1,2,14,22 Ot |
Withdrawn |
Study Name: Safety and Efficacy Study of Humira in Treatment of Pyoderma Gangrenosum Condition: Pyoderma Gangrenosum Date: 2008-08-04 Interventions: Drug: Humira Will receive 80 m |
Withdrawn |
Study Name: Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma Gangrenosum Condition: Pyoderma Gangrenosum Date: 2008-06-02 Interventions: Drug: adalimumab 40 mg weekly adalimumab injection. |